Deepak L. Bhatt, MD, MPH

Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual antiplatelet therapy should last after PCI.

PHILADELPHIA — In this Healio video exclusive, Deepak L. Bhatt, MD, MPH, discusses two hot topics in cardiometabolic medicine: icosapent ethyl and sotagliflozin.

PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.

PHILADELPHIA — In this Healio exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.

In the ONCO-DVT trial, patients with cancer and isolated distal deep vein thrombosis had fewer thrombotic events at 1 year with 12-month vs. 3-month edoxaban therapy, a finding that could change clinical guidance, according to a speaker.

A short course of inorganic dietary nitrate reduced contrast-induced kidney injury in high-risk patients with non-ST segment elevation ACS referred for invasive coronary angiography, researchers reported.

Adults with elevated serum sodium in middle age, a marker of inadequate fluid intake, were more likely to be biologically older than their chronological age and develop chronic diseases compared with adequately hydrated adults, data show.

BOSTON — In the Healio video exclusive, Cardiology Today Intervention Section Editor Deepak L. Bhatt, MD, MPH, discussed late breaking research in renal and pulmonary artery denervation and other trials presented at TCT 2022.

In patients at high bleeding risk, dual antiplatelet therapy for 1 month after PCI lowered bleeding rates and was noninferior for ischemic events compared with 3-month DAPT, according to results of the MASTER DAPT trial.

Administration of high-dose omega-3 carboxylic acid compared with corn oil placebo did not reduce incidence of major adverse CV events among statin-treated adults with elevated triglycerides at high CV risk.